• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

岩藻黄质和岩藻黄醇可增加KKAy肥胖/糖尿病小鼠肝脏中二十二碳六烯酸的含量。

Fucoxanthin and fucoxanthinol enhance the amount of docosahexaenoic acid in the liver of KKAy obese/diabetic mice.

作者信息

Tsukui Takayuki, Konno Kensuke, Hosokawa Masashi, Maeda Hayato, Sashima Tokutake, Miyashita Kazuo

机构信息

Faculty of Fisheries Sciences and Creative Research Institute, Hokkaido University, Hakodate, Hokkaido 041-8611, Japan.

出版信息

J Agric Food Chem. 2007 Jun 27;55(13):5025-9. doi: 10.1021/jf070110q. Epub 2007 May 31.

DOI:10.1021/jf070110q
PMID:17536824
Abstract

This study examined the effect of dietary fucoxanthin or fucoxanthinol on the amount of docosahexaenoic acid (DHA) in the liver of KKAy mice, a model for obese/type II diabetes. In the first experiment, mice were fed diets containing crude fucoxanthin or glyceroglycolipid for 4 weeks. Results showed a significant increase in the level of DHA in mice fed 0.53% crude fucoxanthin, from 2.3% in control mice to 5.1% of fatty acid composition of total liver lipids. On the other hand, in mice fed crude glyceroglycolipid, the level of DHA as a proportion of total liver fatty acids remained unchanged. To clarify the enhancement of hepatic DHA, in the second experiment, KKAy mice were fed a diet containing purified fucoxanthin or its deacetylated derivative, fucoxanthinol. Results from a quantitative analysis using an internal standard showed that in mice fed 0.2% fucoxanthin, the amount of hepatic DHA was 2-fold higher than in control mice, whereas DHA levels in the small intestine remained unchanged. Furthermore, 0.2% fucoxanthinol led to 1.8- and 1.2-fold increases in the amount of hepatic DHA and arachidonic acid compared to control mice, respectively. These results indicate for the first time that dietary fucoxanthin and fucoxanthinol enhance the amount of DHA in the liver of KKAy mice.

摘要

本研究考察了膳食岩藻黄质或岩藻黄醇对肥胖/II型糖尿病模型KKAy小鼠肝脏中二十二碳六烯酸(DHA)含量的影响。在第一个实验中,给小鼠喂食含有粗岩藻黄质或甘油糖脂的饲料4周。结果显示,喂食0.53%粗岩藻黄质的小鼠肝脏中DHA水平显著升高,从对照小鼠肝脏总脂质脂肪酸组成中的2.3%升至5.1%。另一方面,喂食粗甘油糖脂的小鼠肝脏中,DHA占总脂肪酸的比例没有变化。为了阐明肝脏中DHA含量增加的原因,在第二个实验中,给KKAy小鼠喂食含有纯化岩藻黄质或其脱乙酰衍生物岩藻黄醇的饲料。使用内标进行定量分析的结果显示,喂食0.2%岩藻黄质的小鼠肝脏中DHA含量比对照小鼠高出2倍,而小肠中的DHA水平没有变化。此外,与对照小鼠相比,0.2%岩藻黄醇使肝脏中DHA和花生四烯酸的含量分别增加了1.8倍和1.2倍。这些结果首次表明,膳食岩藻黄质和岩藻黄醇可提高KKAy小鼠肝脏中DHA的含量。

相似文献

1
Fucoxanthin and fucoxanthinol enhance the amount of docosahexaenoic acid in the liver of KKAy obese/diabetic mice.岩藻黄质和岩藻黄醇可增加KKAy肥胖/糖尿病小鼠肝脏中二十二碳六烯酸的含量。
J Agric Food Chem. 2007 Jun 27;55(13):5025-9. doi: 10.1021/jf070110q. Epub 2007 May 31.
2
Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites.岩藻黄质醇在小鼠和肝癌细胞系HepG2中转化为amarouciaxanthin A:岩藻黄质代谢产物的形成及细胞毒性
Drug Metab Dispos. 2004 Feb;32(2):205-11. doi: 10.1124/dmd.32.2.205.
3
Radical scavenging and singlet oxygen quenching activity of marine carotenoid fucoxanthin and its metabolites.海洋类胡萝卜素岩藻黄质及其代谢产物的自由基清除和单线态氧猝灭活性
J Agric Food Chem. 2007 Oct 17;55(21):8516-22. doi: 10.1021/jf071848a. Epub 2007 Sep 26.
4
Characterization of fucoxanthin and fucoxanthinol esters in the Chinese surf clam, Mactra chinensis.中国蛤蜊(Mactra chinensis)中岩藻黄质和岩藻黄醇酯的特性分析
J Agric Food Chem. 2007 Feb 21;55(4):1563-7. doi: 10.1021/jf063139n. Epub 2007 Jan 31.
5
Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese/diabetic KK-Ay mice.岩藻黄质与鱼油的饮食组合可减轻肥胖/糖尿病KK-Ay小鼠白色脂肪组织的体重增加并降低血糖。
J Agric Food Chem. 2007 Sep 19;55(19):7701-6. doi: 10.1021/jf071569n. Epub 2007 Aug 23.
6
Halocynthiaxanthin and fucoxanthinol isolated from Halocynthia roretzi induce apoptosis in human leukemia, breast and colon cancer cells.从柄海鞘中分离出的卤化海鞘黄质和岩藻黄质醇可诱导人白血病、乳腺癌和结肠癌细胞凋亡。
Comp Biochem Physiol C Toxicol Pharmacol. 2006 Jan-Feb;142(1-2):53-9. doi: 10.1016/j.cbpc.2005.10.005. Epub 2005 Dec 7.
7
Fucoxanthinol, Metabolite of Fucoxanthin, Improves Obesity-Induced Inflammation in Adipocyte Cells.岩藻黄质的代谢产物岩藻黄醇可改善肥胖诱导的脂肪细胞炎症。
Mar Drugs. 2015 Aug 4;13(8):4799-813. doi: 10.3390/md13084799.
8
Effect of brown seaweed lipids on fatty acid composition and lipid hydroperoxide levels of mouse liver.褐藻脂对小鼠肝脏脂肪酸组成和脂质过氧化物水平的影响。
J Agric Food Chem. 2011 Apr 27;59(8):4156-63. doi: 10.1021/jf104643b. Epub 2011 Mar 30.
9
Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment.岩藻黄质及其代谢产物岩藻黄醇在癌症预防与治疗中的作用
Mar Drugs. 2015 Jul 31;13(8):4784-98. doi: 10.3390/md13084784.
10
Comparative effects between fucoxanthinol and its precursor fucoxanthin on viability and apoptosis of breast cancer cell lines MCF-7 and MDA-MB-231.岩藻黄质醇及其前体岩藻黄质对乳腺癌细胞系MCF-7和MDA-MB-231活力及凋亡的比较作用。
Anticancer Res. 2015 Jan;35(1):207-19.

引用本文的文献

1
Potential of siphonaxanthin, a green algal carotenoid, to prevent obesity and related diseases.绿藻类胡萝卜素虹吸藻黄素预防肥胖及相关疾病的潜力。
J Nat Med. 2025 Apr 12. doi: 10.1007/s11418-025-01897-4.
2
Revolutionizing Diabetes Care: The Role of Marine Bioactive Compounds and Microorganisms.革新糖尿病护理:海洋生物活性化合物和微生物的作用
Cell Biochem Biophys. 2025 Mar;83(1):193-213. doi: 10.1007/s12013-024-01508-1. Epub 2024 Sep 10.
3
: A Factory of Nutraceutical and Food Supplements for Human Health.: 一个生产人类健康用营养保健品和食品补充剂的工厂。
Molecules. 2023 Jan 25;28(3):1185. doi: 10.3390/molecules28031185.
4
Fucoxanthin: A Promising Phytochemical on Diverse Pharmacological Targets.岩藻黄质:一种针对多种药理学靶点的有前景的植物化学物质。
Front Pharmacol. 2022 Aug 2;13:929442. doi: 10.3389/fphar.2022.929442. eCollection 2022.
5
Unlocking the Health Potential of Microalgae as Sustainable Sources of Bioactive Compounds.释放微藻作为生物活性化合物可持续来源的健康潜力。
Int J Mol Sci. 2021 Apr 22;22(9):4383. doi: 10.3390/ijms22094383.
6
Health Benefits of Carotenoids: A Role of Carotenoids in the Prevention of Non-Alcoholic Fatty Liver Disease.类胡萝卜素的健康益处:类胡萝卜素在预防非酒精性脂肪性肝病中的作用
Prev Nutr Food Sci. 2019 Jun;24(2):103-113. doi: 10.3746/pnf.2019.24.2.103. Epub 2019 Jun 30.
7
Seaweeds as Preventive Agents for Cardiovascular Diseases: From Nutrients to Functional Foods.海藻作为心血管疾病的预防剂:从营养成分到功能性食品
Mar Drugs. 2015 Nov 12;13(11):6838-65. doi: 10.3390/md13116838.
8
Fucoxanthin Enhances Chain Elongation and Desaturation of Alpha-Linolenic Acid in HepG2 Cells.岩藻黄质增强HepG2细胞中α-亚麻酸的链延长和去饱和作用。
Lipids. 2015 Oct;50(10):945-53. doi: 10.1007/s11745-015-4059-z. Epub 2015 Aug 14.
9
Fucoxanthin: A Promising Medicinal and Nutritional Ingredient.岩藻黄质:一种有前景的药用和营养成分。
Evid Based Complement Alternat Med. 2015;2015:723515. doi: 10.1155/2015/723515. Epub 2015 May 27.
10
Algae in fish feed: performances and fatty acid metabolism in juvenile Atlantic Salmon.鱼饲料中的藻类:大西洋鲑幼鱼的生长性能及脂肪酸代谢
PLoS One. 2015 Apr 15;10(4):e0124042. doi: 10.1371/journal.pone.0124042. eCollection 2015.